1
a patient scheduled to receive treatment on a Monday included the previous Friday and the 24 following Tuesday. Based on these assumptions, we determine how often each patient would 25 have overlapped with others conditional on when chemotherapy began. We observe with whom 26 overlap and for how long they overlap based on a random sample from the risk set, assuming the 27 periodicity of chemotherapy holds. By repeating this procedure 1000 times for each patient, we 28 create a patient-specific empirical distribution of overlap times, and draw a cutoff at the 99 th 29 percentile of this distribution, forming an edge between the focal actor and the other patient.
30
Formally, this can be written as:
Where H(i) is the set of hours spent in the ward by patient i and Q99 is the 99 th percentile of that 33 patient's co-presence times with other patients based on the empirical distribution. For a visual 34 explanation of this method, see Figure S2 .
35
Thus, an edge in this co-presence network is drawn between two patients when the 36 amount of time spent co-present in the ward is greater than the time at least one of the patients in 37 question spends with 99% of the risk set of patients randomly sampled. We will refer to the 38 edges in this network as an indicator of patients who are "consistently co-present". Unlike the patients are connected when at least one of them was consistently co-present with the other. The 46 resulting network is shown in Figure S3 .
47
Although the method to determine this network is stochastic, over 99% of the ties were 48 the same between runs, we create the network one time using 1000 samples of patient schedules.
49
Using this network, we construct counts, for each focal patient, of the number of connected or 2- 
57
In the consistent co-presence network GEE we fit a term for whether an individual had 58 any significant co-presence (all individuals had at least one weighted edge in the Jaccard index 59 network). The term for whether an individual is an isolate indicates that isolates were more likely 60 to die within five years than those co-present with other patients (0.361 CI:0.195, 0.526) . Thus,
61
patients benefit from significant co-presence with at least one other patient in the ward,
62
irrespective of alters' outcomes.
63
We observe similar effects as those observed when using Jaccard-weighted person-hours 64 for both a significant positive effect between 5-year mortality and the number of consistently co- It should be noted that the GEE does not adjust for the correlation between patients.
97
Patients within two steps of each other may have correlated survival/death counts (e.g. if patients
98
A and B are both connected to patient C, and C survives, A and B's count are correlated) and 99 may also have other unmeasured latent factors which are correlated between them. To examine 100 whether this had an effect on the model inferences, we reran the GEE with random samples of 101 patients who are all at least two steps away from one another and should be largely independent.
102
These models, run using 1000 samples, give results that are generally in the same direction and 103 approximately the same magnitude as the models with all the data included (Table S1 , Model C). (Table S1 , Model D) (Mills, 2011 neighbors set with probability proportional to the Jaccard index with those neighbors, which is 139 written as:
Where Ni is the nurse assigned to patient i.
142
If the nurse is chosen based on the patient's outcome, then a nurse is chosen with 143 probability proportional to the probability of survival if the patient survived, or proportional to 144 the probability of death if the patient died. We assume the nurse heterogeneity parameter relates 145 linearly to the log-odds of survival (because the physician parameters do), and so calculate the 146 probability straightforwardly. For this probability, we assume all patients have the population 147 mean probability of survival (33%) as their baseline which is modified only by the nurse 148 heterogeneity parameter. This is written as:
Where HN(n) is the heterogeneity parameter for nurse n. This results in 95% of probabilities of 151 survival ranging from 12.0% to 64.7%. Assuming the patient survived, a nurse with a 152 heterogeneity parameter at the 97.5 th percentile of the distribution would be chosen 5.4 times association between nurse parameter and patient outcome is not meant to precisely reflect how 155 nurses are assigned in the ward, but rather to fulfill the necessary condition that nurse assignment 156 is correlated with outcome to induce confounding. Each combination of number of nurses and 157 assortativity probability was run 100 times, and the proportion of significant (p<0.05) direct 158 effects were recorded ( Figure S3 ).
159
Overall, we see that the significance of the main findings is relatively robust to the gender. We therefore believe that this assumption of random assignment reflects reality,
176
particularly given the fact that nurses do not specialize beyond general chemotherapy.
Ties concurrent with pre-existing social ties

178
Given that our study population is drawn from a relatively small catchment area, it is 179 possible that our belief that patients in the chemotherapy ward do not know one another prior to 180 initiating chemotherapy is incorrect. However, we believe ties of this sort are very unlikely, as 181 they would stem from the confluence of a number of unlikely events. First, both patients in a 182 dyad would need to be diagnosed with cancer, the lifetime risk of which in the UK is ~50% (UK, edges representing more time co-present in the ward).
13 Table S1 . Results of sensitivity analyses. The first 3 models are GEEs constructed in the same way as the primary analysis but with specific changes. A) Uses the consistent co-presence metric which is dichotomous, and also includes an indicator variable of whether an individual is an isolate or not. B) Treats cancer severity as a categorical variable. C) Is based on a sample of patients who were not co-present with one another to remove correlation between variables. Results are based on 100 trials of sampling a subset of patients in this way. D) Instead of a dichotomous 5-year survival outcome, we treat survival time as the outcome of interest, using a Cox proportional hazards model. γ: For the consistent co-presence measure, the units are total number of paths
